Vitiligo is a skin disorder marked by the loss of pigmentation, leading to the development of white patches on the skin. Effective therapies focus on repigmentation, improving skin appearance, and managing symptoms. Common treatments include topical corticosteroids, which can help restore color in early-stage vitiligo, and calcineurin inhibitors, which reduce inflammation and support skin health.
Phototherapy, particularly narrowband UVB, is another effective option, promoting skin repigmentation through controlled exposure to UV light. For more extensive cases, depigmentation of unaffected areas may be considered to achieve a uniform skin tone. Additionally, cosmetic solutions like makeup and self-tanners can help improve the appearance of vitiligo-affected skin.
Consultation with a dermatologist is essential to tailor treatments based on the individual's specific condition and skin type, ensuring the best possible outcome while prioritizing skin health.
Title : Personalized and precision dermatology through the view of biodesign-inspired translational & data-driven applications: Revolutionary skin treatments for every concern in clinical dermatology integrating skin care experts and consumers
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Personalized and precision medicine as a unique avenue to have the healthcare model renewed to secure the national biosafety: Advanced skincare solutions in individualized cosmetology, reconstructive plastic surgery and the modern beauty
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Unlocking the future of individualized cosmetics and reconstructive plastic surgery: Concepts and future prospects through the precision medical armamentarium tailored to the personalized DNA
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Modern non-invasive methods for in vivo assessment of skin
Georgios N Stamatas, SGS, France
Title : Paraneoplastic autoimmune multiorgan syndrome or PAMS: Paraneoplastic pemphigus revisited
Sergei A Grando, University of California Irvine, United States